GTS-21
Overview[edit | edit source]
GTS-21, also known as DMXB-A, is a synthetic compound that acts as a partial agonist at the _7 nicotinic acetylcholine receptor (_7 nAChR). It has been studied for its potential therapeutic effects in various neurological and cognitive disorders.
Mechanism of Action[edit | edit source]
GTS-21 primarily targets the _7 nAChR, a subtype of nicotinic acetylcholine receptors that are widely distributed in the CNS. By binding to these receptors, GTS-21 modulates the release of neurotransmitters such as dopamine, glutamate, and acetylcholine, which are crucial for cognitive processes.
Potential Therapeutic Uses[edit | edit source]
GTS-21 has been investigated for its potential benefits in treating conditions such as Alzheimer's disease, schizophrenia, and ADHD. Its ability to enhance cognitive function and memory makes it a promising candidate for these disorders.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of GTS-21 involves its absorption, distribution, metabolism, and excretion. It is known to cross the blood-brain barrier, allowing it to exert its effects on the central nervous system. The compound is metabolized in the liver and excreted primarily through the kidneys.
Research and Development[edit | edit source]
Research on GTS-21 has been ongoing, with various clinical trials conducted to assess its efficacy and safety. While some studies have shown positive results, further research is needed to fully understand its therapeutic potential and to address any safety concerns.
Side Effects[edit | edit source]
Like many pharmacological agents, GTS-21 may have side effects. Commonly reported side effects include nausea, headache, and dizziness. It is important for patients to be monitored for any adverse reactions during treatment.
Conclusion[edit | edit source]
GTS-21 represents a promising avenue for the treatment of cognitive and neurological disorders. Its action on the _7 nAChR offers a unique mechanism that could complement existing therapies. Ongoing research will continue to elucidate its role in clinical practice.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
